New remedy for rheumatoid arthritis will be offered by SUS
People with rheumatoid arthritis may have another medication to treatment in the Unified Health System (SUS): tofacitinibe citrate. The SUS has up to 180 days from the last Thursday (2) to make the medicine available in the country.
The remedy is indicated for adults with active, moderate to severe rheumatoid arthritis, with an inadequate response to one or more disease-modifying drugs. Rheumatoid arthritis is an autoimmune, inflammatory, systemic, and chronic disease. In Brazil, a 2004 study showed a prevalence of 0.46%, representing almost one million people with this disease.
The incidence of rheumatoid arthritis disease increases with age and the highest peak is between 30 and 50 years. The female sex is the most affected by the disease, about two to three times in relation to the male sex. If untreated, 20% to 30% of people with rheumatoid arthritis are permanently unable to perform their activities after about three years from diagnosis.
According to the epidemiological bulletin, the Southeast recorded the highest number of reported cases (45,315 cases, 61.3 and the North (3,434 cases, 4.6%), followed by the Midwest (10,372 cases, 14%), the Northeast (7,862 cases, 10,6%), the South (6,889 cases, 9,3% ). In all, 5,777 suspected cases of dengue were discarded.
In the last two weeks I have observed an extremely curious phenomenon, which I dubbed the "Lula effect". No, this is not another political maneuver of our former president, which many believe still greatly influence the direction of power in Brasilia. It is, in fact, an unintended consequence of Lula's enormous popularity, and of the identification of the Brazilian people with this northeastern retreatant who has won in life - but who keeps habits that are not as healthy as the downfall of drink and cigarette.